Aushon BioSystems launched this week new human multiplex biomarker panels for the quantification of eight protein biomarkers related to drug-induced kidney damage.
The panels are validated for analysis of the following biomarkers in urine samples: KIM-1, clusterin, TIMP-1, VEGF, trefoil factor-3, osteopontin, EGF, and NGAL. The panels were developed with the Aushon SearchLight protein array technology and feature a 3.5 hour protocol similar to standard plate-based ELISAs, the company said.
Thermo Fisher Scientific this week added new Thermo Scientific Cysteine-Reactive Tandem Mass Tag Reagents to its isobaric tandem mass tags product line.
The reagents enable protein identification and quantification via selective labeling of cysteine-containing peptides and can be used for multiplex analysis of up to six different samples concurrently, the company said.
Dionex released this week its new UltiMate 3000 NCP-3200RS nano/capillary LC pump module, an ultra-high-pressure pump designed for proteomics research.
The pump can be used for reversed-phase separation of peptides in LC-MS workflows as well as applications like automated off-line 2D-LC or tandem nano LC.
Asset management firm GoIndustry DoveBid announced this week that Pfizer will be selling off surplus assets from its US facilities in a series of weekly auctions.
Items to be auctioned include HPLC and NMR systems as well as mass spectrometers and general lab equipment.